DK2661274T3 - Sammensætninger og fremgangsmåder med aloepolysaccharider - Google Patents

Sammensætninger og fremgangsmåder med aloepolysaccharider Download PDF

Info

Publication number
DK2661274T3
DK2661274T3 DK11854913.8T DK11854913T DK2661274T3 DK 2661274 T3 DK2661274 T3 DK 2661274T3 DK 11854913 T DK11854913 T DK 11854913T DK 2661274 T3 DK2661274 T3 DK 2661274T3
Authority
DK
Denmark
Prior art keywords
aloepolysaccharides
compositions
methods
Prior art date
Application number
DK11854913.8T
Other languages
English (en)
Inventor
Ivan E Danhof
Original Assignee
Bespoke Bioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bespoke Bioscience Llc filed Critical Bespoke Bioscience Llc
Application granted granted Critical
Publication of DK2661274T3 publication Critical patent/DK2661274T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK11854913.8T 2011-01-06 2011-01-06 Sammensætninger og fremgangsmåder med aloepolysaccharider DK2661274T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/020402 WO2012094010A1 (en) 2011-01-06 2011-01-06 Compositions and methods of aloe polysaccharides

Publications (1)

Publication Number Publication Date
DK2661274T3 true DK2661274T3 (da) 2019-08-26

Family

ID=46457644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11854913.8T DK2661274T3 (da) 2011-01-06 2011-01-06 Sammensætninger og fremgangsmåder med aloepolysaccharider

Country Status (17)

Country Link
EP (1) EP2661274B1 (da)
JP (1) JP5886877B2 (da)
KR (5) KR20180120799A (da)
CN (2) CN108503723A (da)
AU (4) AU2011353765B2 (da)
BR (1) BR112013017501B1 (da)
CA (1) CA2822300C (da)
DK (1) DK2661274T3 (da)
ES (1) ES2742220T3 (da)
IL (2) IL227093B (da)
MX (2) MX2013007561A (da)
MY (1) MY194961A (da)
NZ (1) NZ612024A (da)
RU (1) RU2587784C2 (da)
SG (1) SG191336A1 (da)
WO (1) WO2012094010A1 (da)
ZA (1) ZA201304789B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604187B2 (en) 2010-01-14 2013-12-10 North Texas Medical Associates Compositions and methods of aloe polysaccharides
CN103876014B (zh) * 2014-03-31 2015-07-08 福建农林大学 一种复方桑黄口服液及其制备方法
US10456353B2 (en) 2014-04-17 2019-10-29 Conopco, Inc. Personal care compositions
US10449143B2 (en) 2014-04-17 2019-10-22 Conopco, Inc. Aloe vera extract for personal care compositions
US9993416B1 (en) * 2017-04-24 2018-06-12 Shen Wei (Usa) Inc. Hydrating elastomeric flexible article with natural bioactives and manufacturing method
CN110270132A (zh) * 2018-07-20 2019-09-24 何晴雪 一种甜叶菊糖液提取装置的使用方法
CN109320626B (zh) * 2018-10-08 2020-06-23 伍曾利 一种芦荟多糖及其制备方法与应用
CN111467365A (zh) * 2019-01-24 2020-07-31 开封九福来生物技术有限公司 含有石斛多糖的口腔速溶膜剂及其制备方法
WO2022046975A1 (en) * 2020-08-28 2022-03-03 Herbalife International Of America, Inc. Compositions comprising neutral and acidic polysaccharides of aloe vera and their uses
CN115900275A (zh) * 2022-12-15 2023-04-04 宁波伊玛水环境科技有限公司 一种海藻酸钠制备装置及方法
CN116473235B (zh) * 2023-04-30 2025-04-18 海南九面通科技有限公司 芦荟凝胶粉及其与水苏糖的组合物的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2106616A (en) * 1935-11-06 1938-01-25 Locke Insulator Corp Switch and bus insulator stack
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US5118673A (en) * 1982-05-07 1992-06-02 Carrington Laboratories, Inc. Uses of aloe products
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
WO1999019505A1 (en) * 1997-10-10 1999-04-22 Univera Pharmaceuticals, Inc. Process for the preparation of immunomodulatory polysaccharides from aloe
US20030096378A1 (en) * 1997-10-10 2003-05-22 Univera Pharmaceuticals, Inc. Process for the preparation of immunomodulatory polysaccharides from aloe
US6482942B1 (en) * 1999-01-12 2002-11-19 Biotechnology Services And Consulting, Inc. Method of isolating mucilaginous polysaccharides and uses thereof
AU2002218748A1 (en) * 2000-07-10 2002-01-21 The University Of Mississippi High molecular weight polysaccharide fraction from aloe vera with immunostimulatory activity
CN1362105A (zh) * 2001-01-04 2002-08-07 杨孟君 纳米当归龙荟制剂药物及其制备方法
KR20020075622A (ko) * 2001-03-26 2002-10-05 김세웅 고기 구이장치
US20080063675A1 (en) * 2004-05-21 2008-03-13 Shunichi Yagi Aloe Powder, Aloe Juice, and Method for Producing the Same
US20060084629A1 (en) * 2004-10-15 2006-04-20 Alvin Needleman Immune system activating formula composed of selected long chain polysaccharides from natural sources
CN101070354B (zh) * 2007-05-18 2010-04-07 中南大学 一种利用芦荟同时生产芦荟多糖粉、芦荟活性水的方法
CN101306012A (zh) * 2008-06-19 2008-11-19 中国人民解放军第四军医大学 富含甘露糖的改性多糖在制备阻止结肠炎癌变的药物中的应用

Also Published As

Publication number Publication date
CN103338781A (zh) 2013-10-02
JP2014501777A (ja) 2014-01-23
KR20170038085A (ko) 2017-04-05
AU2019200361B2 (en) 2020-07-30
AU2017202499B2 (en) 2018-12-06
IL253716B (en) 2020-03-31
ES2742220T3 (es) 2020-02-13
BR112013017501A2 (pt) 2016-09-27
MX2013007561A (es) 2013-12-02
AU2011353765A1 (en) 2013-07-04
AU2020250236A1 (en) 2020-11-05
KR20170015554A (ko) 2017-02-08
IL227093B (en) 2018-04-30
CA2822300A1 (en) 2012-07-12
NZ612024A (en) 2015-02-27
SG191336A1 (en) 2013-07-31
IL253716A0 (en) 2017-09-28
CN108503723A (zh) 2018-09-07
MY194961A (en) 2022-12-28
EP2661274A1 (en) 2013-11-13
RU2587784C2 (ru) 2016-06-20
BR112013017501B1 (pt) 2020-10-27
AU2011353765B2 (en) 2017-04-06
MX358484B (es) 2018-08-22
KR20180122031A (ko) 2018-11-09
JP5886877B2 (ja) 2016-03-16
KR101725584B1 (ko) 2017-04-10
RU2013127633A (ru) 2015-02-20
KR20180120799A (ko) 2018-11-06
KR20140092235A (ko) 2014-07-23
AU2020250236B2 (en) 2022-09-29
CA2822300C (en) 2021-07-20
AU2017202499A1 (en) 2017-05-04
AU2019200361A1 (en) 2019-02-07
ZA201304789B (en) 2014-12-23
WO2012094010A1 (en) 2012-07-12
EP2661274A4 (en) 2014-08-20
EP2661274B1 (en) 2019-05-22

Similar Documents

Publication Publication Date Title
DK3366143T3 (da) Probiotiske sammensætninger og fremgangsmåder
DK2929031T5 (da) Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf
DK2768321T3 (da) Fremgangsmåder og sammensætninger til induktion af mæthed
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2872153T3 (da) Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2683731T3 (da) C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf
DK3662932T3 (da) Anti-cgrp-sammensætninger og anvendelse deraf
PL2922850T3 (pl) Związki i sposoby ich stosowania
PL2704737T3 (pl) Terapeutyczne kompozycje nukleaz i sposoby
DK2763665T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
BR112014010450A2 (pt) composição e método
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2720561A4 (en) Stevia-COMPOSITION
EP2713762A4 (en) Stevia-COMPOSITION
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
DK2793895T3 (da) Fremgangsmåder og sammensætninger til reducering af kropsfedt og adipocytter
DK2476317T3 (da) Mandeldrikke og fremgangsmåder til fremstilling deraf
DK2723347T3 (da) Forebyggelse og behandling af inflammationstilstande
BR112014006291A2 (pt) composição e utilização da composição
SG2014012926A (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
PL3400958T3 (pl) Kompozycje i metody leczenia celiakii
DK2680829T3 (da) Sammensætninger og metoder til ikke-kirurgisk behandling af ptosis